OKYO Pharma, Urcosimod, NEPTUNE, Neuropathic Corneal Pain, NCP, Corneal Pain, Ophthalmology, Eye Disease, Anterior Segment Eye Disease, ChemR23, Chemerin Peptide,

LONDON and NEW YORK — October 6, 2026 OKYO Pharma Limited announced that the first patients have been enrolled...